Insurance, Pharmaceutical Services
"Insurance, Pharmaceutical Services" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Insurance providing for payment of services rendered by the pharmacist. Services include the preparation and distribution of medical products.
Concept/Terms
Insurance, Pharmaceutical Services- Insurance, Pharmaceutical Services
- Pharmacy Services Insurance
- Pharmaceutic Services Insurance
- Pharmaceutical Services Insurance
- Insurance, Pharmaceutic Services
- Insurance, Pharmacy Services
Drug Benefit Plans- Drug Benefit Plans
- Drug Benefit Plan
- Plan, Drug Benefit
- Plans, Drug Benefit
Below are MeSH descriptors whose meaning is more general than "Insurance, Pharmaceutical Services".
Below are MeSH descriptors whose meaning is more specific than "Insurance, Pharmaceutical Services".
This graph shows the total number of publications written about "Insurance, Pharmaceutical Services" by people in Harvard Catalyst Profiles by year, and whether "Insurance, Pharmaceutical Services" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 2 | 1 | 3 |
1998 | 1 | 0 | 1 |
1999 | 2 | 1 | 3 |
2000 | 0 | 1 | 1 |
2001 | 6 | 0 | 6 |
2002 | 3 | 1 | 4 |
2003 | 11 | 7 | 18 |
2004 | 11 | 6 | 17 |
2005 | 10 | 5 | 15 |
2006 | 11 | 3 | 14 |
2007 | 11 | 2 | 13 |
2008 | 5 | 5 | 10 |
2009 | 6 | 4 | 10 |
2010 | 3 | 7 | 10 |
2011 | 5 | 4 | 9 |
2012 | 3 | 3 | 6 |
2013 | 2 | 4 | 6 |
2014 | 4 | 1 | 5 |
2015 | 4 | 1 | 5 |
2016 | 2 | 1 | 3 |
2017 | 4 | 3 | 7 |
2018 | 2 | 3 | 5 |
2019 | 2 | 2 | 4 |
2020 | 2 | 1 | 3 |
2021 | 3 | 3 | 6 |
2022 | 0 | 2 | 2 |
2023 | 0 | 2 | 2 |
Below are the most recent publications written about "Insurance, Pharmaceutical Services" by people in Profiles.
-
Reforming Pharmacy Benefit Managers - A Review of Bipartisan Legislation. N Engl J Med. 2023 Nov 02; 389(18):1640-1643.
-
Complex Picture of Prescription Drug Discount Programs and Out-of-Pocket Costs in Cardiovascular Disease. Circ Cardiovasc Qual Outcomes. 2023 10; 16(10):e010329.
-
Effects of Real-time Prescription Benefit Recommendations on Patient Out-of-Pocket Costs: A Cluster Randomized Clinical Trial. JAMA Intern Med. 2022 11 01; 182(11):1129-1137.
-
Payer-Specific Negotiated Prices for Prescription Drugs at Top-Performing US Hospitals. JAMA Intern Med. 2022 01 01; 182(1):83-86.
-
How Do Commercial Insurance Plans Fare Under Proposed Prescription Drug Price Regulation? JAMA Health Forum. 2021 12 03; 2(12):e214242.
-
Will Ending the Medicaid Drug Rebate Cap Lower Drug Prices? JAMA Intern Med. 2021 08 01; 181(8):1034-1035.
-
Association Between Cost-Saving Prescription Policy Changes and Adherence to Chronic Disease Medications: an Observational Study. J Gen Intern Med. 2022 02; 37(3):531-538.
-
US Trends in Opioid Access Among Patients With Poor Prognosis Cancer Near the End-of-Life. J Clin Oncol. 2021 09 10; 39(26):2948-2958.
-
The Future of Drug-Pricing Transparency. N Engl J Med. 2021 02 11; 384(6):489-491.
-
Price Is Right: Exploring Prescription Drug Coverage Barriers for Irritable Bowel Syndrome Using Threshold Pricing Analysis. Dig Dis Sci. 2021 12; 66(12):4140-4148.